Answer
Desferrioxamine mesilate (Desferal) treats chronic iron overload, including transfusional haemosiderosis in patients receiving regular transfusions and primary or secondary haemochromatosis when concomitant disorders, such as severe anaemia, hypoproteinaemia, renal or cardiac failure, preclude phlebotomy.
Sources for this answer
- Desferal Vials, 500mgNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 14Document updated
Sources checked